Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Glaukos Corporation
This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant to timolol ophthalmic solution in patients with open-angle glaucoma. Study assessments will include IOP and medication use as well as safety parameters.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Open angle glaucoma
You may not be if
Uveitic, neovascular, or angle closure glaucoma; or glaucoma associated with vascular disorders.
Functionally significant visual field loss, including severe nerve fiber bundle defects.
Prior glaucoma surgery.
Uncontrolled systemic disease, pregnant females or those planning a pregnancy.
Other ocular status conditions, etc.
Clareo Health | Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution
